FILTER

Refine your search with the following facets to narrow down your results.

16 Current news of University of York

New insights into dendron gene delivery

19-Jul-2010 - Gene therapy has the potential to revolutionise personal medicine but delivering the genes into cells is a major challenge. Dendrons offer a potential solution as their many ligands bind strongly to DNA but now scientists are reporting that smaller dendrons with fewer ligands can actually be ...

cholesterol density gene therapy +4

Developing enzymes to clean up pollution by explosives

13-Oct-2009 - Scientists at the University of York have uncovered the structure of an unusual enzyme which can be used to reverse the contamination of land by explosives. The discovery, by scientists in the York Structural Biology Laboratory and the Centre for Novel Agricultural Products, will support the ...

bacteria chemistry enzymes +4

Research points to potential chink in cancer's armor

07-Oct-2009 - Scientists at the University of York have identified and successfully silenced a gene that appears essential to cancer cell survival. Professor Jo Milner and Dr Shafiq Ahmed, from the YCR P53 Research Unit in the Department of Biology, used a process called RNA interference to target the JNK2 ...

biology breast cancer chemotherapy +4

Medical use for waste television screens

16-Jul-2009 - Waste material from discarded televisions could be recycled and used in medicine, according to new research by scientists at the University of York. The chemical compound polyvinyl-alcohol (PVA) is widely used in industry and is a key element of television sets with liquid crystal display (LCD) ...

liquid crystals medicine recycling +1

Biological warfare in bacteria offers hope for new antibiotics

06-Jul-2009 - Scientists are to study a group of proteins that are highly effective at killing bacteria and which could hold the key to developing new types of antibiotics. Researchers from the Universities of York and Leeds have been awarded £3.3m from the Biotechnology and Biological Sciences Research ...

antibiotics bacteria biology +6

Asterion Raises £355k Funding to Progress Novel Therapies for Hormone Related Diseases

16-May-2006 - Biofusion plc announced that its portfolio company Asterion Ltd, the Sheffield-based drug development company has raised £355k to progress its novel therapies for hormone-related diseases. Biofusion led the round, investing £250k. The White Rose Technology Seedcorn Fund ("WRTSF"), the venture ...

cytokines diseases drug development +2